3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
4
Stomach Neoplasms
3
Pancreatic Neoplasms
3
Lung Neoplasms
2
Carcinoma, Renal Cell
2
Adenocarcinoma Of Esophagus
2
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Triple Negative Breast Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Ovarian Neoplasms
1
Lung Diseases
1
Kidney Neoplasms
1
Esophageal Neoplasms
1
Erythrocytosis, Familial, 4
1
Cholangiocarcinoma
1
Advanced Non-Small Cell Lung Cancer
1
Interventions
Dexamethasone
40
Lenalidomide
26
Bortezomib
21
daratumumab
20
pomalidomide
19
Cyclophosphamide
14
Specimen Handling
13
Biopsy
13
carfilzomib
12
talquetamab
9
Magnetic Resonance Spectroscopy
9
Calcium Dobesilate
9
isatuximab
8
Melphalan
8
iberdomide
7
fludarabine
7
belantamab mafodotin
6
X-Rays
5
selinexor
4
fludarabine phosphate
4
elotuzumab
4
Nuclear Medicine Department, Hospital
4
trametinib
3
tocilizumab
3
dexamethasone acetate
3
dexamethasone 21-phosphate
3
dabrafenib
3
auricularum
3
Whole-Body Irradiation
3
Thalidomide
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Multiple Myeloma
×
zimberelimab
×
30 days
×
Clear all
No trials found.